Drug nonadherence prevalent in type 2 diabetes patients

07/25/2013 | InternalMedicineNews.com (free registration)

Research presented at the ADA 73rd Scientific Sessions showed the one-year drug discontinuation rate among type 2 diabetes patients was 89% in those taking a GLP-1 agonist, 82% in those who took a DPP-4 inhibitor and 84% in those treated with other diabetes drugs. The findings highlight the need for better persistence with GLP-1 agonist therapy, the lead researcher said.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ